Search hospitals > Washington > Seattle
Seattle Children's Hospital
Claim this profileSeattle, Washington 98105
Global Leader in Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Brain Tumor
Conducts research for Solid Tumors
Conducts research for Neuroblastoma
1025 reported clinical trials
77 medical researchers
Summary
Seattle Children's Hospital is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, Adult T-Cell Leukemia/Lymphoma, Brain Tumor, Solid Tumors, Neuroblastoma and other specialties. Seattle Children's Hospital is involved with conducting 1,025 clinical trials across 1,336 conditions. There are 77 research doctors associated with this hospital, such as Sarah Leary, MD, Navin Pinto, MD, Simon Horslen, MD, and Catherine Albert, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Adult T-Cell Leukemia/Lymphoma
Global LeaderCD19 positive
CD22 positive
Stage IV
Top PIs
Sarah Leary, MDSeattle Children's Hospital8 years of reported clinical research
Expert in Brain Tumor
Expert in Cancer
78 reported clinical trials
139 drugs studied
Navin Pinto, MDSeattle Children's Hospital3 years of reported clinical research
Expert in Neuroblastoma
Studies Osteosarcoma
24 reported clinical trials
38 drugs studied
Simon Horslen, MDUPMC Children's Hospital of Pittsburgh17 years of reported clinical research
Studies Liver Dysfunction
Studies Liver Disease
9 reported clinical trials
8 drugs studied
Catherine Albert, MDSeattle Children's Hospital Research Foundation5 years of reported clinical research
Studies Soft Tissue Sarcoma
Studies Osteosarcoma
8 reported clinical trials
14 drugs studied
Clinical Trials running at Seattle Children's Hospital
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Cancer
Brain Cancer
Testicular cancer
Acute Lymphoblastic Leukemia
Adult T-Cell Leukemia/Lymphoma
Chronic Kidney Disease
Testicular Carcinoma
Ovarian Carcinoma
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
DAY101 vs. Chemotherapy
for Pediatric Brain Cancer
This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
Combination Therapy
for Brain Cancer
This trial is testing a combination of three drugs to treat a specific type of brain tumor called diffuse midline gliomas (DMGs). These drugs aim to stop the tumor from growing by blocking enzymes that the cancer cells need. The trial focuses on patients with DMGs because current treatments are not very effective for them.
Recruiting1 award Phase 229 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Seattle Children's Hospital?
Where is Seattle Children's Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Seattle Children's Hospital accept?
What awards or recognition has Seattle Children's Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.